Groundbreaking prenatal treatment trial for devastating Boy's disease
NCT ID NCT04143295
Summary
This study is testing a treatment for a rare genetic disorder called MCT8 deficiency, which causes severe intellectual and movement disabilities in boys. The treatment is given to the mother during pregnancy, with the goal of helping the baby's brain develop more normally. The study is for families who have a confirmed diagnosis in their unborn son and have decided to continue the pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MCT8 (SLC16A2)-SPECIFIC THYROID HORMONE CELL TRANSPORTER DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami, Miller School of Medicine
AVAILABLEMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.